Virtual reality stimulation to reduce the incidence of delirium in critically ill patients: study protocol for a randomized clinical trial.

Background: Delirium has been long considered as a major contributor to cognitive impairments and increased mortality following a critical illness. Pharmacologic and non-pharmacologic strategies are used against delirium in the intensive care unit (ICU), despite these strategies remaining controvers...

Descripción completa

Detalles Bibliográficos
Publicado en:Trials Vol. 22; no. 1; pp. 1 - 13
Autores principales: Naef, Aileen C., Jeitziner, Marie-Madlen, Gerber, Stephan M., Jenni-Moser, Béatrice, Müri, René M., Jakob, Stephan M., Nef, Tobias, Hänggi, Matthias
Formato: Journal Article
Publicado: BioMed Central 3/1/2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=149023947&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 149023947
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        17456215
        38OC
      jtl: Trials
      issn: 17456215
      maglogo: N
    pubinfo:
      dt: 3/1/2021
      vid: 22
      iid: 1
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        149023947
        149023947
        NLM33648572
        10.1186/s13063-021-05090-2
        NLM33648572
        149023947
      ppf: 1
      ppct: 12
      formats:
      tig:
        atl: Virtual reality stimulation to reduce the incidence of delirium in critically ill patients: study protocol for a randomized clinical trial.
      aug:
        au:
          Naef, Aileen C.
          Jeitziner, Marie-Madlen
          Gerber, Stephan M.
          Jenni-Moser, Béatrice
          Müri, René M.
          Jakob, Stephan M.
          Nef, Tobias
          Hänggi, Matthias
        affil: Gerontechnology and Rehabilitation Group, University of Bern, Bern, Switzerland
      sug:
        subj:
          Delirium Epidemiology
          Delirium Prevention and Control
          Delirium Diagnosis
          Clinical Trials
          Critical Illness
          Incidence
          Intensive Care Units
          Critical Care Family Needs Inventory
      ab: Background: Delirium has been long considered as a major contributor to cognitive impairments and increased mortality following a critical illness. Pharmacologic and non-pharmacologic strategies are used against delirium in the intensive care unit (ICU), despite these strategies remaining controversial. Previous studies have shown the feasibility of using virtual reality within the ICU setting, and we propose to use this technology to investigate the effect of immersive virtual reality stimulation on the incidence of delirium in the ICU. Moreover, we propose to use motion sensors to determine if patient movement patterns can lead to early prediction of delirium onset.Methods: This study is conducted as a randomized clinical trial. A total of 920 critically ill patients in the ICU will participate. The control group will receive standard ICU care, whereas the intervention group will, in addition to the standard ICU care, receive relaxing 360-degree immersive virtual reality content played inside a head-mounted display with noise-cancelling headphones, three times a day. The first 100 patients, regardless of their group, will additionally have their movement patterns recorded using wearable and ambient sensors. Follow-up measurements will take place 6 months after discharge from the ICU.Discussion: Delirium is widely present within the ICU setting but lacks validated prevention and treatment strategies. By providing patients with virtual reality stimulation presented inside a head-mounted display and noise-cancelling headphones, participants may be isolated from disturbances on an ICU. It is believed that by doing so, the incidence of delirium will be decrease among these patients. Moreover, identifying movement patterns associated with delirium would allow for early detection and intervention, which may further improve long-term negative outcomes associated with delirium during critical care.Trial Registration: ClinicalTrials.gov NCT04498585 . Registered on August 3, 2020.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N